Besides the ICAM-1/LFA-1 proteins, it is likely that other cell surface proteins are also modulated by GSK3 in both NK cells and target cells that also impact NK/target cell conjugate formation and subsequent AML cell killing. This evidence concerns the gene ICAM1 and acute myeloid leukemia.